Literature DB >> 16115517

Therapy for diastolic heart failure.

William C Little1, Steffen Brucks.   

Abstract

There is little objective to guide the therapy of patients with diastolic heart failure. Because of the similarities of pathophysiology abnormalities in diastolic and systolic heart failure, it is a reasonable inference to suggest that the proven therapy for systolic heart failure may also be of benefit in patients with diastolic heart failure. Treatment of underlying or exacerbating conditions in diastolic heart failure, such as hypertension, left ventricular hypertrophy, ischemia, diabetes, anemia, obesity and pulmonary disease is an important means of managing diastolic heart failure. Control of systolic blood pressure is effective in improving and preventing the development of diastolic heart failure. Treatment of diastolic heart failure is most effective when it is associated with hypertension. Production of systolic arterial pressure acutely reduces pulmonary congestion, ischemia, and chronically may lead to regression of left ventricular hypertrophy. Patients with diastolic heart failure in the absence of hypertension are very difficult to treat.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16115517     DOI: 10.1016/j.pcad.2005.02.004

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  14 in total

1.  Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease.

Authors:  Hao-jian Dong; Cheng Huang; De-mou Luo; Jing-guang Ye; Jun-qing Yang; Guang Li; Jian-fang Luo; Ying-ling Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

Review 2.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

Review 3.  Office management of patients with diastolic heart failure.

Authors:  Katina Tzanetos; Derek Leong; Robert C Wu
Journal:  CMAJ       Date:  2009-03-03       Impact factor: 8.262

4.  Left atrial volume index is an independent predictor of hypertensive response to exercise in patients with hypertension.

Authors:  Sang-Eun Lee; Jong-Chan Youn; Hye Sun Lee; Sungha Park; Sang-Hak Lee; In-Jeong Cho; Chi Young Shim; Geu-Ru Hong; Donghoon Choi; Seok-Min Kang
Journal:  Hypertens Res       Date:  2014-09-25       Impact factor: 3.872

Review 5.  Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis.

Authors:  Chirag Bavishi; Saurav Chatterjee; Sameer Ather; Dipen Patel; Franz H Messerli
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

6.  Diastolic function predicts survival after renal revascularization.

Authors:  Racheed J Ghanami; Hamza Rana; Timothy E Craven; John Hoyle; Matthew S Edwards; Kimberley J Hansen
Journal:  J Vasc Surg       Date:  2011-08-06       Impact factor: 4.268

7.  Advances in diastolic heart failure.

Authors:  Xing Sheng Yang; Jing Ping Sun
Journal:  World J Cardiol       Date:  2010-03-26

Review 8.  Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment.

Authors:  Barry A Borlaug; Walter J Paulus
Journal:  Eur Heart J       Date:  2010-12-07       Impact factor: 29.983

9.  Treatment of heart failure with preserved ejection fraction.

Authors:  Barry A Borlaug
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

10.  Heart failure with a normal left ventricular ejection fraction: diastolic heart failure.

Authors:  William C Little
Journal:  Trans Am Clin Climatol Assoc       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.